Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

• James Larkin,
• Jeffrey Weber,
• Victoria Atkinson,
• Michael Millward,
• Ivan Marquez-Rodas,
• Luis de la Cruz-Merino,
• Helen Gogas,
• Paolo A Ascierto,
• Anna Maria Di Giacomo,
• Veerle de Pril,
• Vanna Chiarion-Sileni,
• Stephane Dalle,
• Leslie Fecher,
• Ana Arance,
• Jean-Jacques Grob,
• Nikhil I Khushalani,
• Michele Del Vecchio,
• Mario Mandala,
• C Lance Cowey,
• Michael Schenker,
• Petr Arenberger,
• Maurice Lobo

Affiliations

James Larkin

2 Royal Marsden NHS Foundation Trust, London, UK

Jeffrey Weber

24 Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA

Victoria Atkinson

17 Gallipoli Medical Research Foundation and University of Queensland, Brisbane, Queensland, Australia

Michael Millward

21 Sir Charles Gairdner Hospital, University of Western Australia, Nedlands, Western Australia, Australia

Ivan Marquez-Rodas

Aff3 0000 0001 0277 7938grid.410526.4Medical Oncology DepartmentHospital General Universitario Gregorio Marañón Madrid Spain

Luis de la Cruz-Merino

16 Clinical Oncology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain

Helen Gogas

5 First Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

Paolo A Ascierto

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

Anna Maria Di Giacomo

14 Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy

Veerle de Pril

23 Bristol Myers Squibb, Princeton, New Jersey, USA

Vanna Chiarion-Sileni

11 Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Stephane Dalle

8 Hospices Civils de Lyon, Pierre Bénite, France

Leslie Fecher

20 Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA

Ana Arance

7 Hospital Clínic de Barcelona, Barcelona, Spain

Jean-Jacques Grob

10 Aix-Marseille University, APHM Hospital, Marseille, France

Nikhil I Khushalani

22 Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA

Michele Del Vecchio

4 Unit of Melanoma Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Mario Mandala

1 Unit of Medical Oncology, University of Perugia, Perugia, Italy

C Lance Cowey

6 Texas Oncology Baylor Charles A Sammons Cancer Center, Dallas, Texas, USA

Michael Schenker

9 Oncology Center Sf Nectarie Ltd, Craiova, Romania

Petr Arenberger

18 University Hospital Královské, Vinohrady, Czech Republic

Maurice Lobo

23 Bristol Myers Squibb, Princeton, New Jersey, USA